MM
VIR icon

MWG Management’s Vir Biotechnology VIR Stock Holding History

MWG Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-74,743
Closed -$3.53M – 5
2021
Q2 		$3.53M Sell
74,743
-250,257
-77% -$11.4M 0.35% 4
2021
Q1 		$16.7M Buy
325,000
+324,675
+99,900% +$17.5M 8.1% 2
2020
Q4 		$8.7K Buy
+325
New +$10.6K 5.52% 2

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MWG Management's VIR Position: Q3 2021 in Review

MWG Management sold out of Vir Biotechnology (VIR) in Q3 2021, closing a stake of 74,743 shares — an estimated $3.53M sold.

MWG Management first reported a position in VIR in Q4 2020 and held it in 3 quarters. The position peaked at $16.7M in Q1 2021. 175 funds tracked by Wall St. Rank hold VIR as of Q3 2021.

  • MWG Management reported no remaining Vir Biotechnology position as of Q3 2021 after selling out during the quarter.
  • MWG Management sold 74,743 Vir Biotechnology shares in Q3 2021, an estimated $3.53M.
  • MWG Management first reported a position in Vir Biotechnology in Q4 2020 and held it in 3 quarters.
  • MWG Management's Vir Biotechnology position peaked at $16.7M in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2021.

Based on MWG Management's 13F filing for Q3 2021, filed 15 Nov 2021.